Assignee
ACTIVE BIOTECH AB
SE·37 granted patents·14 pending applications·893 citations·filing 1995–2025
Top patents by PatentIndex Score
51 records- 0195US7615225B2Methods for treating a subject having cancer by the administration of a conjugate between a variant staphylococcal entertoxin E superantigen and an antibody that binds to the 5T4 antigenACTIVE BIOTECH AB·Filed 2006·Granted Nov 10, 2009·52 cites·51 claims
- 0295US6875869B2Process for the manufacture of quinoline derivativesACTIVE BIOTECH AB·Filed 2003·Granted Apr 5, 2005·79 cites·6 claims
- 0394US7763253B2Treatment of hyperproliferative disease with superantigens in combination with another anticancer agentACTIVE BIOTECH AB·Filed 2005·Granted Jul 27, 2010·63 cites·57 claims
- 0494US7125554B2Engineered superantigen for human therapyACTIVE BIOTECH AB·Filed 2001·Granted Oct 24, 2006·71 cites·49 claims
- 0594US6593343B2Quinoline derivativesACTIVE BIOTECH AB·Filed 2002·Granted Jul 15, 2003·60 cites·15 claims
- 0694US6077851AQuinoline derivativesACTIVE BIOTECH AB·Filed 1999·Granted Jun 20, 2000·139 cites·40 claims
- 0793US7589208B2Compositions containing quinoline compoundsACTIVE BIOTECH AB·Filed 2005·Granted Sep 15, 2009·51 cites·32 claims
- 0893US7226595B2Modified Chimeric superantigens and their useACTIVE BIOTECH AB·Filed 2002·Granted Jun 5, 2007·69 cites·9 claims
- 0993US6395750B1Drugs for the treatment of malignant tumorsACTIVE BIOTECH AB·Filed 2000·Granted May 28, 2002·79 cites·66 claims
- 1092US6605616B1Quinoline derivativesACTIVE BIOTECH AB·Filed 2000·Granted Aug 12, 2003·40 cites·18 claims
- 1188US11478465B2Compounds for treatment of eye diseases associated with excessive vascularisationACTIVE BIOTECH AB·Filed 2021·Granted Oct 25, 2022·4 cites·15 claims
- 1287US6133285AQuinoline derivativesACTIVE BIOTECH AB·Filed 1999·Granted Oct 17, 2000·62 cites·41 claims
- 1385US6121287AQuinoline derivativesACTIVE BIOTECH AB·Filed 1999·Granted Sep 19, 2000·68 cites·38 claims
- 1485US2025134881A1Treatment of ocular inflammatory diseases using laquinimodACTIVE BIOTECH AB·Filed 2024·Application pending·0 cites
- 1583US7074831B2Compounds, methods for their preparation and use thereofACTIVE BIOTECH AB·Filed 2005·Granted Jul 11, 2006·10 cites·17 claims
- 1678US9956212B2Quinoline carboxamides for use in the treatment of multiple myelomaACTIVE BIOTECH AB·Filed 2015·Granted May 1, 2018·4 cites·20 claims
- 1774US7553849B2CompoundsACTIVE BIOTECH AB·Filed 2005·Granted Jun 30, 2009·2 cites·21 claims
- 1873US6642249B2Immunomodulating compoundsACTIVE BIOTECH AB·Filed 2002·Granted Nov 4, 2003·8 cites·22 claims
- 1973US2021386731A1Treatment of ocular inflammatory diseases using laquinimodACTIVE BIOTECH AB·Filed 2021·Application pending·0 cites
- 2073US2026076908A1Plurality of tasquinimod particles and use thereofACTIVE BIOTECH AB·Filed 2025·Application pending·0 cites
- 2171US12485095B2Plurality of tasquinimod particles and use thereofACTIVE BIOTECH AB·Filed 2022·Granted Dec 2, 2025·0 cites·17 claims
- 2271US6518312B2Immune enhancementACTIVE BIOTECH AB·Filed 2001·Granted Feb 11, 2003·4 cites·14 claims
- 2370US7291612B2Immunomodulatory compoundsACTIVE BIOTECH AB·Filed 2006·Granted Nov 6, 2007·2 cites·19 claims
- 2467US12208091B2Compounds for treatment of eye diseases associated with excessive vascularisationACTIVE BIOTECH AB·Filed 2022·Granted Jan 28, 2025·0 cites·15 claims
- 2567US10300053B2Quinoline carboxamides for use in the treatment of leukemiaACTIVE BIOTECH AB·Filed 2015·Granted May 28, 2019·1 cites·18 claims
- 2666US7226601B1Conjugate between a modified superantigen and a target-seeking compound and the use of the conjugateACTIVE BIOTECH AB·Filed 1995·Granted Jun 5, 2007·13 cites·2 claims
- 2765US7425623B2Antibody with specificity for colon cancerACTIVE BIOTECH AB·Filed 2001·Granted Sep 16, 2008·2 cites·13 claims
- 2864US2010111978A1Conjugates between a variant staphylococcal enterotoxin e superantigen and a targeting antibody that binds to a cancer-associated cell surface structureACTIVE BIOTECH AB·Filed 2009·Application pending·0 cites
- 2963US11654140B2Treatment of ocular inflammatory diseases using laquinimodACTIVE BIOTECH AB·Filed 2017·Granted May 23, 2023·0 cites·25 claims
- 3062US10314836B2Quinoline carboxamides for use in the treatment of multiple myelomaACTIVE BIOTECH AB·Filed 2018·Granted Jun 11, 2019·0 cites·12 claims
- 3162US7081456B2Immunomodulatory compoundsACTIVE BIOTECH AB·Filed 2003·Granted Jul 25, 2006·2 cites·20 claims
- 3261US8754104B2Crystalline salts of quinoline compounds and methods for preparing themACTIVE BIOTECH AB·Filed 2012·Granted Jun 17, 2014·0 cites·20 claims
- 3361US7189816B1CompoundsACTIVE BIOTECH AB·Filed 2000·Granted Mar 13, 2007·4 cites·10 claims
- 3461US2005226885A1Cytolysis of target cells by superantigen conjugates inducing T-cell activationACTIVE BIOTECH AB·Filed 2004·Application pending·0 cites
- 3560US10385069B2Imidazo[2,1-B]thiazole and 5,6-dihydroimidazo[2,1-B]thiazole derivatives useful as S100-inhibitorsACTIVE BIOTECH AB·Filed 2015·Granted Aug 20, 2019·1 cites·18 claims
- 3660US2024091215A1Tasquinimod or a pharmaceutically acceptable salt thereof for use in the treatment of myelodysplastic syndromeACTIVE BIOTECH AB·Filed 2022·Application pending·0 cites
- 3759US2024122915A1Combination of tasquinimod or a pharmaceutically acceptable salt thereof and a pd-1 and/or pd-l1 inhibitor, for use as a medicamentACTIVE BIOTECH AB·Filed 2023·Application pending·0 cites
- 3855US2024277693A1A pharmaceutical product containing tasquinimod and a method for assessing the purity of said productACTIVE BIOTECH AB·Filed 2022·Application pending·0 cites
- 3954US2007112179A1Novel compoundsACTIVE BIOTECH AB·Filed 2006·Application pending·0 cites
- 4052US12582643B2Tasquinimod or a pharmaceutically acceptable salt thereof for use in combination therapyACTIVE BIOTECH AB·Filed 2021·Granted Mar 24, 2026·0 cites·13 claims
- 4152US2024180819A1Laquinimod formulation for ocular useACTIVE BIOTECH AB·Filed 2022·Application pending·0 cites
- 4250US9873687B2N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitorsACTIVE BIOTECH AB·Filed 2014·Granted Jan 23, 2018·0 cites·21 claims
- 4350US2004146531A1Virus-like particles devoid of HPV 16 type-specific antibody epitopes as carriers of peptides for introduction into cellsACTIVE BIOTECH AB·Filed 2004·Application pending·0 cites
- 4449US2020129499A1Combination of tasquinimod or a pharmaceutically acceptable salt thereof and a pd-1 and/or pd-l1 inhibitor, for use as a medicamentACTIVE BIOTECH AB·Filed 2019·Application pending·0 cites
- 4546US10125125B2N-(heteroaryl)-sulfonamide derivatives useful as S100-inhibitorsACTIVE BIOTECH AB·Filed 2017·Granted Nov 13, 2018·0 cites·39 claims
- 4641US7339059B2Benzofurans and indolsACTIVE BIOTECH AB·Filed 2004·Granted Mar 4, 2008·0 cites·3 claims
- 4740US7674906B2Tetracyclic immunomodulatory compoundsACTIVE BIOTECH AB·Filed 2003·Granted Mar 9, 2010·0 cites·16 claims
- 4840US2008119485A1Novel Benzofurans and IndolsACTIVE BIOTECH AB·Filed 2008·Application pending·0 cites
- 4935US6727062B1Identification of target structures E.G. in vivo selection method for a phage libraryACTIVE BIOTECH AB·Filed 1999·Granted Apr 27, 2004·3 cites·34 claims
- 5031US2005192289A1Novel cinnamic amidesACTIVE BIOTECH AB·Filed 2004·Application pending·0 cites
Showing the top 50 of 51 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →